SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-005477
Filing Date
2019-04-16
Accepted
2019-04-16 16:40:01
Documents
65
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1397349
2 ex-21.htm EX-21 2473
3 ex23-1.htm EX-23.1 4232
4 ex31-1.htm EX-31.1 17230
5 ex31-2.htm EX-31.2 17900
6 ex32.htm EX-32 8651
  Complete submission text file 0001493152-19-005477.txt   6888229

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE rspi-20181231.xml EX-101.INS 1206787
8 XBRL SCHEMA FILE rspi-20181231.xsd EX-101.SCH 83939
9 XBRL CALCULATION FILE rspi-20181231_cal.xml EX-101.CAL 51792
10 XBRL DEFINITION FILE rspi-20181231_def.xml EX-101.DEF 316712
11 XBRL LABEL FILE rspi-20181231_lab.xml EX-101.LAB 538943
12 XBRL PRESENTATION FILE rspi-20181231_pre.xml EX-101.PRE 401299
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16467 | Film No.: 19751380
SIC: 2834 Pharmaceutical Preparations